Eutropics Pharmaceuticals - Product Pipeline Analysis, 2013 Update - New Report Available
Eutropics Pharmaceuticals (Eutropics) is a diagnostic service provider. The company develops a novel test to guide cancer treatment. Eutropics's BH3-profiling biomarker technology visualizes and targets the cause of the cancer. The company's BH3 profiling assay provides a biomarker that is used in the pre clinical development of experimental drugs and guides the use of marketed cancer drugs. Eutropics provides tests for established and experimental cancer therapies. It offers therapies for the treatment of blood cancers, small cell lung cancers and...
View full press release